Detalles de la búsqueda
1.
Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
Blood
; 2024 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657242
2.
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 386(4): 351-363, 2022 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904799
3.
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study.
Haematologica
; 109(2): 553-566, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37646664
4.
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Haematologica
; 109(2): 543-552, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37560813
5.
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
Hematol Oncol
; 42(1): e3235, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37942762
6.
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Br J Haematol
; 202(4): 776-784, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37386877
7.
Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV-2 booster vaccination in hematologic neoplasms.
Am J Hematol
; 98(8): 1204-1213, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151135
8.
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.
Histopathology
; 81(6): 826-840, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109172
9.
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Blood
; 133(11): 1205-1216, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30602617
10.
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma.
Haematologica
; 2021 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407608
11.
Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma.
Haematologica
; 106(9): 2417-2426, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34196165
12.
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas.
Haematologica
; 106(2): 513-521, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32079701
13.
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysis.
Ann Hematol
; 100(12): 2969-2978, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378095
14.
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy.
Ann Hematol
; 100(9): 2303-2310, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34236497
15.
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative.
Ann Hematol
; 100(3): 825-830, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33409623
16.
Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
Br J Haematol
; 190(6): 854-863, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519351
17.
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO).
Br J Haematol
; 188(6): 888-897, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31782146
18.
Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition.
J Neurooncol
; 149(1): 13-25, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32691208
19.
Venetoclax-obinutuzumab: harnessing complexity.
Blood
; 135(11): 788-789, 2020 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32163557
20.
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.
Blood
; 122(24): 3951-9, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24124086